Scholar Rock's Muscle-Sparing Drug Tackles GLP-1's Biggest Side Effect — But the Trial Is Tiny and the Funder Is the Maker

Scholar Rock's Muscle-Sparing Drug Tackles GLP-1's Biggest Side Effect — But the Trial Is Tiny and the Funder Is the Maker | BedrockNews